Answers are grounded in this paper and cite their sources.
Graft versus host disease (GVHD) remains a significant source of morbidity and mortality in the setting of allogeneic stem cell transplantation. Skin involvement is reported to be as high as 70-95 % in this group with GVHD and the severity of the involvement varies widely. Surgical management of complications of severe cutaneous GVHD is uncommon and is rarely mentioned as a treatment option.
No takes yet. Share an insight, caveat, or question.
Nash et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: